Pure Global

Prospective Observational Study of Systemic Therapy for HCC in Japan: Exploratory Biomarker-Analysis - Trial UMIN000048298

Access comprehensive clinical trial information for UMIN000048298 through Pure Global AI's free database. This phase not specified trial is sponsored by Investigator Initiated Study Promotion Center none and is currently Recruiting. The study focuses on Hepatocellular carcinoma.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048298
Recruiting
Trial Details
University Hospital Medical Information Network โ€ข UMIN000048298
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Prospective Observational Study of Systemic Therapy for HCC in Japan: Exploratory Biomarker-Analysis
Multicenter Observational Study to Evaluate Factors Related to Angiogenesis and Tumor Immunity in Unresectable Hepatocellular Carcinoma

Study Focus

Hepatocellular carcinoma

Observational

Sponsor & Location

Investigator Initiated Study Promotion Center none

Japan

Timeline & Enrollment

N/A

Jul 15, 2022

N/A

ICD-10 Classifications

Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure

Data Source

University Hospital Medical Information Network

UMIN000048298

Non-Device Trial